Theravance Biopharma, founded with a mission to transform the treatment of specialty respiratory and neurologic diseases, focuses on the discovery, development, and commercialization of small molecule medicines. The company's vision centers on creating "Medicines that Make a Difference" in patients' and caregivers' lives. Their product pipeline includes treatments for respiratory disease, bacterial infections, and central nervous system disorders, addressing significant patient needs in these therapeutic areas.

Notable affiliates of Theravance Biopharma include a team of experienced scientists and industry professionals dedicated to innovative drug development. The company has attracted substantial investment from leading healthcare investors, contributing to its robust research and development capabilities. Key achievements include the successful advancement of multiple drug candidates through clinical trials, significantly impacting patient care in their target markets. Theravance Biopharma continues to be a pivotal player in the biopharmaceutical industry, driving forward advancements in specialty medicine.